SCHEMBL6979984

SCHEMBL6979984

CC(C)(C)OC(=O)N1CCN(C(=O)C2CCN(S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1

nearest known ligand 0.74

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.74
CNR1 P21554 1/20 0.68
NPSR1 Q6W5P4 1/20 0.64
STS P08842 2/20 0.63
ALDH1A1 P00352 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
LMNA P02545 1/20 0.58
TGM2 P21980 2/20 0.56
F13A1 P00488 1/20 0.56
TGM1 P22735 1/20 0.56
POLB P06746 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
TSHR P16473 1/20 0.56
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6982617 0.93 GAA (0.65) GAACNR1NPSR1STSALDH1A1
SCHEMBL6970591 0.89 GAA (0.72) GAACNR1NPSR1ALDH1A1SMN1; SMN2
SCHEMBL7086266 0.89 ALDH1A1 (0.59) GAAALDH1A1LMNATGM2F13A1
SCHEMBL5253160 0.88 POLB (0.70) GAACNR1STSLMNATGM2
SCHEMBL5736874 0.87 F10 (0.64) GAACNR1NPSR1STSSMN1; SMN2
SCHEMBL6980123 0.86 LSS (0.60) GAACNR1ALDH1A1LMNATGM2
SCHEMBL6972262 0.82 NPC1 (0.56) GAAALDH1A1TGM2F13A1TGM1
SCHEMBL6787216 0.80 KMT2A (0.65) GAAALDH1A1SMN1; SMN2LMNARAB9A
SCHEMBL14016492 0.80 STS (0.56) GAACNR1STSTGM2F13A1
SCHEMBL6974195 0.79 EPHX2 (0.53) STSTGM2F13A1TGM1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925286-B1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ASTRAZENECA AB (SE) 2003-01-02 EP disclosed
US-6093718-A AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS ZENECA LIMITED (GB) 2000-07-25 US disclosed
EP-0925286-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ZENECA LIMITED (GB) 1999-06-30 EP disclosed
WO-1998006705-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE ZENECA LIMITED (GB) 1998-02-19 WO disclosed